FilingReader Intelligence

Alivus Life Sciences reports strong Q1 growth

August 1, 2025 at 07:06 PM UTCBy FilingReader AI

Alivus Life Sciences reported Q1 FY26 revenue of ₹6,018m, up 2.2% year-on-year, with EBITDA rising 9.9% to ₹1,813m and profit growing 9.0% to ₹1,215m.

The company's Non-GPL business grew 14.5% while GPL contributed around 25% of total revenue. Free cash flow reached ₹1,000m.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Glenmark Life Sciences publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →